Log in
Enquire now
‌

US Patent 7317091 Optimized Fc variants

Patent 7317091 was granted and assigned to Xencor on January, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Xencor
Xencor
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
73170910
Patent Inventor Names
Wei Dang0
Arthur J. Chirino0
Gregory Alan Lazar0
John R. Desjarlais0
Omid Vafa0
Robert J. Hayes0
Sher Bahadur Karki0
Stephen Kohl Doberstein0
Date of Patent
January 8, 2008
0
Patent Application Number
108222310
Date Filed
March 26, 2004
0
Patent Citations Received
‌
US Patent 12134632 On-column viral inactivation methods
0
‌
US Patent 11987617 Antibodies that target HIV GP120 and methods of use
0
‌
US Patent 12006368 Anti-frizzled antibodies and methods of use
0
‌
US Patent 12017050 Drug depot delivery system and method
0
‌
US Patent 12018068 Anti-O1 antibodies and uses thereof
0
‌
US Patent 12024569 HER2/neu-specific antibodies and methods of using same
0
‌
US Patent 12076519 Drug delivery device and methods having a retaining member
0
‌
US Patent 12077790 Optimized binuclease fusions and methods
0
...
Patent Primary Examiner
‌
Phillip Gambel
0
Patent abstract

The present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7317091 Optimized Fc variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.